RAPT Therapeutics (RAPT) Change in Cash (2020 - 2024)
Historic Change in Cash for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $131.8 million.
- Therapeutics' Change in Cash rose 208039.66% to $131.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $122.3 million, marking a year-over-year increase of 133292.31%. This contributed to the annual value of $122.3 million for FY2024, which is 133292.31% up from last year.
- As of Q4 2024, Therapeutics' Change in Cash stood at $131.8 million, which was up 208039.66% from $823000.0 recorded in Q3 2024.
- Therapeutics' Change in Cash's 5-year high stood at $131.8 million during Q4 2024, with a 5-year trough of -$62.6 million in Q2 2020.
- Moreover, its 5-year median value for Change in Cash was $2.4 million (2023), whereas its average is $4.6 million.
- In the last 5 years, Therapeutics' Change in Cash plummeted by 86715.72% in 2021 and then skyrocketed by 433787.88% in 2022.
- Over the past 5 years, Therapeutics' Change in Cash (Quarter) stood at $4.7 million in 2020, then crashed by 867.16% to -$36.0 million in 2021, then soared by 131.25% to $11.2 million in 2022, then crashed by 159.23% to -$6.7 million in 2023, then soared by 2080.4% to $131.8 million in 2024.
- Its Change in Cash stands at $131.8 million for Q4 2024, versus $823000.0 for Q3 2024 and -$8.2 million for Q2 2024.